Cargando…

WHO Grade IV Gliofibroma: A Grading Label Denoting Malignancy for an Otherwise Commonly Misinterpreted Neoplasm

We report a 50-year-old woman with no relevant clinical history who presented with headache and loss of memory. Magnetic resonance imaging showed a left parieto-temporal mass with annular enhancement after contrast media administration, rendering a radiological diagnosis of high-grade astrocytic neo...

Descripción completa

Detalles Bibliográficos
Autores principales: Escalante Abril, Paola A., Salazar, Miguel Fdo., López García, Nubia L., Madrazo Moya, Mónica N., Zamora Guerra, Yadir U., Mata Mendoza, Yadira Gandhi, Gómez Apo, Erick, Chávez Macías, Laura G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Pathologists and the Korean Society for Cytopathology 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508570/
https://www.ncbi.nlm.nih.gov/pubmed/26081826
http://dx.doi.org/10.4132/jptm.2015.05.20
_version_ 1782381949632905216
author Escalante Abril, Paola A.
Salazar, Miguel Fdo.
López García, Nubia L.
Madrazo Moya, Mónica N.
Zamora Guerra, Yadir U.
Mata Mendoza, Yadira Gandhi
Gómez Apo, Erick
Chávez Macías, Laura G.
author_facet Escalante Abril, Paola A.
Salazar, Miguel Fdo.
López García, Nubia L.
Madrazo Moya, Mónica N.
Zamora Guerra, Yadir U.
Mata Mendoza, Yadira Gandhi
Gómez Apo, Erick
Chávez Macías, Laura G.
author_sort Escalante Abril, Paola A.
collection PubMed
description We report a 50-year-old woman with no relevant clinical history who presented with headache and loss of memory. Magnetic resonance imaging showed a left parieto-temporal mass with annular enhancement after contrast media administration, rendering a radiological diagnosis of high-grade astrocytic neoplasm. Tumour sampling was performed but the patient ultimately died as a result of disease. Microscopically, the lesion had areas of glioblastoma mixed with a benign mesenchymal constituent; the former showed hypercellularity, endothelial proliferation, high mitotic activity and necrosis, while the latter showed fascicles of long spindle cells surrounded by collagen and reticulin fibers. With approximately 40 previously reported cases, gliofibroma is a rare neoplasm defined as either glio-desmoplastic or glial/benign mesenchymal. As shown in our case, its prognosis is apparently determined by the degree of anaplasia of the glial component.
format Online
Article
Text
id pubmed-4508570
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher The Korean Society of Pathologists and the Korean Society for Cytopathology
record_format MEDLINE/PubMed
spelling pubmed-45085702015-07-21 WHO Grade IV Gliofibroma: A Grading Label Denoting Malignancy for an Otherwise Commonly Misinterpreted Neoplasm Escalante Abril, Paola A. Salazar, Miguel Fdo. López García, Nubia L. Madrazo Moya, Mónica N. Zamora Guerra, Yadir U. Mata Mendoza, Yadira Gandhi Gómez Apo, Erick Chávez Macías, Laura G. J Pathol Transl Med Case Study We report a 50-year-old woman with no relevant clinical history who presented with headache and loss of memory. Magnetic resonance imaging showed a left parieto-temporal mass with annular enhancement after contrast media administration, rendering a radiological diagnosis of high-grade astrocytic neoplasm. Tumour sampling was performed but the patient ultimately died as a result of disease. Microscopically, the lesion had areas of glioblastoma mixed with a benign mesenchymal constituent; the former showed hypercellularity, endothelial proliferation, high mitotic activity and necrosis, while the latter showed fascicles of long spindle cells surrounded by collagen and reticulin fibers. With approximately 40 previously reported cases, gliofibroma is a rare neoplasm defined as either glio-desmoplastic or glial/benign mesenchymal. As shown in our case, its prognosis is apparently determined by the degree of anaplasia of the glial component. The Korean Society of Pathologists and the Korean Society for Cytopathology 2015-07 2015-06-17 /pmc/articles/PMC4508570/ /pubmed/26081826 http://dx.doi.org/10.4132/jptm.2015.05.20 Text en © 2015 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Study
Escalante Abril, Paola A.
Salazar, Miguel Fdo.
López García, Nubia L.
Madrazo Moya, Mónica N.
Zamora Guerra, Yadir U.
Mata Mendoza, Yadira Gandhi
Gómez Apo, Erick
Chávez Macías, Laura G.
WHO Grade IV Gliofibroma: A Grading Label Denoting Malignancy for an Otherwise Commonly Misinterpreted Neoplasm
title WHO Grade IV Gliofibroma: A Grading Label Denoting Malignancy for an Otherwise Commonly Misinterpreted Neoplasm
title_full WHO Grade IV Gliofibroma: A Grading Label Denoting Malignancy for an Otherwise Commonly Misinterpreted Neoplasm
title_fullStr WHO Grade IV Gliofibroma: A Grading Label Denoting Malignancy for an Otherwise Commonly Misinterpreted Neoplasm
title_full_unstemmed WHO Grade IV Gliofibroma: A Grading Label Denoting Malignancy for an Otherwise Commonly Misinterpreted Neoplasm
title_short WHO Grade IV Gliofibroma: A Grading Label Denoting Malignancy for an Otherwise Commonly Misinterpreted Neoplasm
title_sort who grade iv gliofibroma: a grading label denoting malignancy for an otherwise commonly misinterpreted neoplasm
topic Case Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508570/
https://www.ncbi.nlm.nih.gov/pubmed/26081826
http://dx.doi.org/10.4132/jptm.2015.05.20
work_keys_str_mv AT escalanteabrilpaolaa whogradeivgliofibromaagradinglabeldenotingmalignancyforanotherwisecommonlymisinterpretedneoplasm
AT salazarmiguelfdo whogradeivgliofibromaagradinglabeldenotingmalignancyforanotherwisecommonlymisinterpretedneoplasm
AT lopezgarcianubial whogradeivgliofibromaagradinglabeldenotingmalignancyforanotherwisecommonlymisinterpretedneoplasm
AT madrazomoyamonican whogradeivgliofibromaagradinglabeldenotingmalignancyforanotherwisecommonlymisinterpretedneoplasm
AT zamoraguerrayadiru whogradeivgliofibromaagradinglabeldenotingmalignancyforanotherwisecommonlymisinterpretedneoplasm
AT matamendozayadiragandhi whogradeivgliofibromaagradinglabeldenotingmalignancyforanotherwisecommonlymisinterpretedneoplasm
AT gomezapoerick whogradeivgliofibromaagradinglabeldenotingmalignancyforanotherwisecommonlymisinterpretedneoplasm
AT chavezmaciaslaurag whogradeivgliofibromaagradinglabeldenotingmalignancyforanotherwisecommonlymisinterpretedneoplasm